SCHEMBL19494474

SCHEMBL19494474

CNc1sc([S+]([O-])c2c(Cl)cc(F)cc2Cl)cc1C(N)=O

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NNMT P40261 1/20 0.37
▸ IKBKB O14920 4/20 0.34
▸ JAK2 O60674 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ EIF2AK2 P19525 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ CFTR P13569 3/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MAPK8 P45983 1/20 0.30
▸ GPR52 Q9Y2T5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494932 0.80 IKBKB (0.43) IKBKBJAK2KMT2AMEN1EIF2AK2
SCHEMBL19494507 0.77 IKBKB (0.40) IKBKBJAK2KMT2AMEN1EIF2AK2
SCHEMBL19494765 0.69 CFTR (0.54) IKBKBJAK2KMT2AMEN1EIF2AK2
SCHEMBL19494736 0.68 JAK2 (0.32) IKBKBJAK2KMT2AMEN1NPC1
SCHEMBL19494388 0.68 MEN1 (0.36) NNMTIKBKBKMT2AMEN1NPC1
SCHEMBL19494654 0.64 NNMT (0.35) NNMTIKBKBJAK2KMT2AMEN1
SCHEMBL16263935 0.64 JAK2 (0.42) IKBKBJAK2KMT2AMEN1EIF2AK2
SCHEMBL19494741 0.63 CFTR (0.49) IKBKBJAK2KMT2AMEN1EIF2AK2
SCHEMBL19494397 0.63 CFTR (0.44) IKBKBJAK2KMT2AMEN1EIF2AK2
SCHEMBL19494898 0.62 JAK2 (0.45) IKBKBJAK2KMT2AMEN1EIF2AK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback